The Intercept @theintercept
Remdesivir has boosted hopes and sent Gilead’s stock price (and according to some analysts, the entire stock market) soaring, but the drug doesn’t seem to do much for coronavirus patients. https://t.co/vlqdBTveBN — PolitiTweet.org